Market Overview

Trump Tax Code Initiatives May Increase The Bear Case For H&R Block

Share:
Trump Tax Code Initiatives May Increase The Bear Case For H&R Block

Trump’s victory in the U.S. presidential election is a negative for H & R Block Inc (NYSE: HRB), and the new Refund Advance product spells greater risk to margins than was earlier anticipated, Morgan Stanley’s Thomas Allen said in a report. He downgraded the rating on the company form Overweight to Equal Weight, while reducing the price target from $26 to $25.

Although H&R Block’s volume growth would likely accelerate in FY 2017, the stock currently reflects “a more balanced” risk to return ratio, Allen mentioned.

Increased Risks

“We believe that the election outcome increases the medium-term bear case risk from tax code simplification and ACA (Affordable Care Act) reform, while removing a bull case driver of immigration amnesty,” Allen wrote.

Although an ACA repeal could take a few years to implement, it is a “cornerstone of Trump's candidacy” and would eliminate a tailwind that the industry has enjoyed for the past few years, the analyst noted. He added that the broader tax code/system simplification presents “another risk.”

H&R Block’s new Refund Advance product is a new loan product that enables early season filers to get their refunds quickly. While such products offered a tailwind initially, the benefit has diminished since the product has become more commonplace, Allen stated. He pointed out further that these loans are not priced as margin drivers, which spells incremental risks for H&R Block’s margins.

At last check, H&R Block was down 6.99 percent at $22.23.

Image Credit: By Michael Rivera (Own work) [CC BY-SA 3.0 ] via Wikimedia Commons

Latest Ratings for HRB

DateFirmActionFromTo
Dec 2019MaintainsEqual-Weight
Nov 2019Initiates Coverage OnHold
Aug 2019MaintainsEqual-Weight

View More Analyst Ratings for HRB
View the Latest Analyst Ratings

Posted-In: Analyst Color News Downgrades Health Care Price Target Politics Analyst Ratings Movers Best of Benzinga

 

Related Articles (HRB)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
VIACJP MorganReinstates50.0
NUVASVB LeerinkMaintains92.0
SRPTCantor FitzgeraldMaintains211.0
SRPTPiperJaffrayMaintains210.0
LULUGoldman SachsMaintains219.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Teva Pharmaceuticals Hit With A Slew Of Downgrades Following Guidance Revision

Why Mobileye Bears Are Missing The Big Picture